Lv31
370 积分 2024-04-08 加入
Structure-Based Mechanistic Insights into DNMT1-Mediated Maintenance DNA Methylation
21天前
已完结
Multi-targeted HDAC Inhibitors as Anticancer Agents: Current Status and Future Prospective
23天前
已完结
PLASMA PHARMACOKINETICS AND METABOLISM OF THE HISTONE DEACETYLASE INHIBITOR TRICHOSTATIN A AFTER INTRAPERITONEAL ADMINISTRATION TO MICE
25天前
已完结
先导化合物结构优化策略(六)——改善化合物血浆稳定性
25天前
已完结
Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy
30天前
已完结
Multitargeting HDAC Inhibitors Containing a RAS/RAF Protein Interfering Unit
1个月前
已完结
Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma
1个月前
已完结
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo Efficacy
1个月前
已完结
Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
1个月前
已完结
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
1个月前
已完结
皖公网安备34019202002308
